Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

BACKGROUND: Hypertension (HTN) is a common toxicity of anti-VEGF (vascular endothelial growth factor) antibody treatment. It may be a marker of VEGF signalling pathway inhibition and therefore represent a cancer biomarker in metastatic colorectal cancer (mCRC) patients treated with chemotherapy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Österlund, P, Soveri, L-M, Isoniemi, H, Poussa, T, Alanko, T, Bono, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049598/
https://www.ncbi.nlm.nih.gov/pubmed/21304526
http://dx.doi.org/10.1038/bjc.2011.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049598/
https://www.ncbi.nlm.nih.gov/pubmed/21304526
http://dx.doi.org/10.1038/bjc.2011.2

Ejemplares similares